Theravalues, Inc.   Report issue

For profit Phase 2
Founded: Tokyo Japan (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2011
NCT01201694
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now